Loading...
Barriers to buprenorphine expansion in Ohio: A time-elapsed qualitative study
Buprenorphine partial opioid agonist pharmacotherapy, a key treatment for opioid use disorders (OUDs), is underutilized in the United States. Qualitative interviews, conducted in 2012/2013 and repeated in 2015, identified systemic barriers to providing buprenorphine treatment in Ohio. A representati...
Na minha lista:
| Udgivet i: | J Psychoactive Drugs |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6667294/ https://ncbi.nlm.nih.gov/pubmed/30732542 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/02791072.2019.1566583 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|